Trial Profile
Study of the Safety and Tolerance of Three Doses of G17DT in Patients With Metastatic Colorectal Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2014
Price :
$35
*
At a glance
- Drugs Polyclonal antibody stimulator (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cancer Advances
- 03 Sep 2014 New trial record